Joseph J Ferra Jr is CHIEF EXECUTIVE OFFICER of Elevation Oncology, Inc.. Currently has a direct ownership of 145,085 shares of ELEV, which is worth approximately $55,132. The most recent transaction as insider was on Dec 16, 2022, when has been sold 12,562 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 145K
8.92% 3M change
54.98% 12M change
Total Value Held $55,132

Joseph J Ferra Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2022
BUY
Exercise of conversion of derivative security
-
12,562 Added 19.61%
51,505 Common Stock
Sep 16 2022
SELL
Payment of exercise price or tax liability
$5,966 $1.25 p/Share
4,773 Reduced 10.92%
38,943 Common Stock
Sep 16 2022
BUY
Exercise of conversion of derivative security
-
12,562 Added 22.32%
43,716 Common Stock
Jun 16 2022
SELL
Payment of exercise price or tax liability
$24,059 $1.26 p/Share
19,095 Reduced 38.0%
31,154 Common Stock
Jun 16 2022
BUY
Exercise of conversion of derivative security
-
50,249 Added 50.0%
50,249 Common Stock

Also insider at

SYRS
Syros Pharmaceuticals, Inc. Healthcare
JJF

Joseph J Ferra Jr

CHIEF EXECUTIVE OFFICER
Cambridge, MA

Track Institutional and Insider Activities on ELEV

Follow Elevation Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELEV shares.

Notify only if

Insider Trading

Get notified when an Elevation Oncology, Inc. insider buys or sells ELEV shares.

Notify only if

News

Receive news related to Elevation Oncology, Inc.

Track Activities on ELEV